To Evaluate The Safety and Efficacy of STSA-1002 Injection in Patients With Acute Respiratory Distress Syndrome

NCT07208591 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

406

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Respiratory Distress Syndrome (ARDS)

Interventions

DRUG: STSA-1002 injection
DRUG: STSA-1002 Injection Placebo

Sponsor

Staidson (Beijing) Biopharmaceuticals Co., Ltd